Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous ketamine for prevention of post-dural puncture headache after spinal anesthesia in elective cesarean section
PACTR202203511463759Phase 2Not yet recruiting
- Sponsor
- Ain Shams University Hospitals
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of ketamine in post-dural puncture headache (PDPH) (2 arms), sponsored by Ain Shams University Hospitals. Primary endpoints: Incidence of headache and Severity of headache. Planned start Apr 2022; status: not yet recruiting.
02
Drugs
ketamine
03
Conditions
post-dural puncture headache (PDPH)
Beyond the preview
Go deeper on PACTR202203511463759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202203511463759.